Neupogen
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
RATIONALE & OBJECTIVES: Biosimilar filgrastim may offer significant cost advantages over originator filgrastim and pegfilgrastim…
Solid-organ transplant graft-versus-host disease (SOT-GVHD) is a rare complication of organ transplant that is associated with…
Methods: A PDMDD model was developed by combining elements from a cell-level model of target interaction [1] with a traditional…
Background : There are little differences between biosimilars and reference products. Therefore, these products must be compared…
Aim: To demonstrate biosimilarity as evidenced by the pharmacokinetic (PK), pharmacodynamics (PD), efficacy and safety…
Objectives: Offspring of women with gestational diabetes mellitus (GDM) are at increased risk for obesity and diabetes mellitus…
The authors present their own observation of a patient suffering from drug-induced agranulocytosis, cured with filgastrim…
A home intravenous drug therapy provider and an insurance company operated by the American Consulting Engineers Council have…
High‐dose melphalan (HDM) is now a standard treatment for multiple myeloma (MM). Stem cell transplants are fast evolving as an…
Neupogen, or recombinant granulocyte colony-stimulating factor, is a neutrophil growth factor developed by Amgen. Neupogen has…